NantKwest Reports Positive Interim Data In Pancreatic Cancer Trials, Stock Soars
January 14, 2021 at 09:19 AM EST
Clinical-stage immunotherapy company Nantkwest Inc NK reports positive interim data on survival rates in the Metastatic Pancreatic Cancer QUILT 88 trial on Wednesday.